News

The PQT-IVD team held a joint assessment session from 5-9 June in Geneva session to pilot a new assessment model whereby assessors meet for a week during which they work in groups to assess product

The PQT Medicines 6th Annual Medicines Quality Workshop for Manufacturers will take place from 25 to 28 September 2023.

The Prequalification Unit (PQT) is happy to announce the introduction of a revised webpage for the List of Prequalified Active Pharmaceutical Ingredients (APIs).

A second Invitation to Manufacturers of therapeutics against Ebola Virus Disease to submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit is being published

The United Nations Development Programme (UNDP) procures diagnostic tests for Global Fund-supported programmes and supports Member States in accessing high-quality in vitro diagnostics (IVDs), incl

The Prequalification-In Vitro Diagnostics (IVD) team were invited by the US President’s Emergency Plan for AIDS Relief (PEPFAR) to present an overview of the current prequalification process for in

The WHO In Vitro Diagnostics (IVD) Assessment team held a meeting and trained assessors from 2 to 5 May in Geneva, Switzerland.

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

The World Health Organization Prequalification Team - Medicines (PQT Medicines) will be attending the Shanghai SNIEC CPhi on 19-21 June 2023, in Shanghai, China.

Updated guidance on the development of zinc sulfate product dossiers for submission to PQT/MED has been posted to the PQT/MED website.

WHO Prequalification Unit (PQT) added the below new product to its prequalified list:

The following API was added: